share_log

Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $7

Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $7

莱克街维持对Evaxion Biotech的买入,将目标价下调至7美元
Benzinga ·  2023/03/31 09:28

Lake Street analyst Thomas Flaten maintains Evaxion Biotech (NASDAQ:EVAX) with a Buy and lowers the price target from $18 to $7.

莱克街分析师托马斯·弗拉滕维持Evaxion Biotech(纳斯达克股票代码:EVAX)的买入,并将目标股价从18美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发